Peter S Klein Denali Therapeutics Inc. (DNLI) insider trading activity

DNLI Quotes by TradingView

Peter S Klein is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 21,496 shares of DNLI, which is worth approximately $443,032. The most recent transaction as insider was on May 31, 2024, when has been sold 5,967 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.5K
0% 3M change
38.42% 12M change
Total Value Held $443,032

Peter S Klein Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2024
BUY
Grant, award, or other acquisition
-
5,967 Added 21.73%
21,496 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
4,216 Added 21.35%
15,529 Common Stock
Jun 02 2022
BUY
Grant, award, or other acquisition
-
5,986 Added 34.6%
11,313 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
2,074 Added 28.02%
5,327 Common Stock
Jun 01 2021
BUY
Exercise of conversion of derivative security
-
3,253 Added 50.0%
3,253 Common Stock

Also insider at

FFIV
F5, INC. Technology
Director
ACCD
Accolade, Inc. Healthcare
Director
STRC
Sarcos Technology & Robotics Corp Technology
Director
PSK

Peter S Klein

Director
Seattle, WA

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNLI